Abraham Heifets, former Atomwise CEO (Atomwise via website)
October 2, 2024 10:48 AM EDT
People
AI

Scoop: Found­ing CEO leaves Atom­wise, cast­ing doubt over a once high-fly­ing AI start­up 

Andrew Dunn

Senior Biopharma Correspondent

Atom­wise’s found­ing CEO Abra­ham Heifets has left the com­pa­ny af­ter a dozen years, End­points News has learned, in the lat­est chal­lenge for one of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ex­clu­sive: Af­ter dis­cov­er­ing an­tibi­otics with AI, a 31-year-old first-time CEO rais­es $17M to fight ag­ing

Lil­ly in­vests $4.5B in new In­di­ana site to bring clin­i­cal man­u­fac­tur­ing in-house

UK biotech bags $43M in Se­ries A to move Hunt­ing­ton's drug in­to first hu­man study

Triveni to take ex­per­i­men­tal eczema drug to the clin­ic, backed by new $115M fi­nanc­ing round

J&J and Bay­er to lay off al­most 300 staffers in New Jer­sey

sponsored

3 Tiers for AAV Po­ten­cy As­say De­vel­op­ment Suc­cess

A service from the Financial Times